Picture of Egetis Therapeutics AB (publ) logo

EGTX Egetis Therapeutics AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Egetis Submits Patent Application To US Patent And Trademark Office

Sept 19 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * EGETIS SUBMITS A PATENT APPLICATION TO THE UNITED STATES
PATENT
AND TRADEMARK OFFICE FOR “PROCESSES OF PREPARATION” OF
TIRATRICOL
    * IF GRANTED, THIS WOULD BE A SIGNIFICANT PATENT EGETIS HAS
OBTAINED FOR INVESTIGATIONAL DRUG TIRATRICOL
    * GENERALLY, EXCLUSIVITY TERM OF A NEW PATENT IS 20 YEARS
FROM
DATE ON WHICH APPLICATION FOR PATENT WAS FILED IN UNITED STATES

Source text for Eikon:  ID:nMFN7kC8rR 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Egetis Therapeutics AB (publ)

See all news